Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Nov 11, 2016 2:27pm

206 Views

Post# 25450932

Money for about 10 months, more or less

Would that be enough cash runway to complete ph 2a (the remaining six patients)? Any thoughts or comments would be welcome. BTW, my calculation of cash consumption assumes the TLC-2000 business continues to be a net drain on cash.

Bullboard Posts

A Look into the Future of Chronic Pain Management